REGN Court Ruling Analysis

Latest settled — T+20d

REGN ▼ -2.33% at T+20d

NEUTRAL call ✗ call lost -2.33% · α vs SPY -14.93% · entry $746.75 → $729.36

Next anchor: T+60d in 14d

Last close $611.34 (close Jun 8) · -18.13% from $746.75 entry

Entry anchored
Mar 27, 03:59 PM ET
via Databento tick

T+1d

+3.12%

call +3.12% · α +0.23%

$770.08

settled 2mo ago

T+5d

+1.75%

call +1.75% · α -2.55%

$759.81

settled 2mo ago

T+20d

-2.33%

call -2.33% · α -14.93%

$729.36

settled 6w ago

T+60d

—

call — · α —

—

in 14d

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The case 'Fraioli v. Regeneron Pharmaceuticals, Inc.' was filed in the Southern District of Florida, but no substantive ruling or opinion text is accessible to assess the outcome, financial exposure, or business impact.

Court Ruling Details

Court

United States District Court for the Southern District of Florida

Court Level

District

Case Type

other

Ruling Type

other

Outcome

NULL

Will It Be Appealed?

N/A (final)

Precedent Risk

LOW

Actionable Insight

Monitor for future docket updates or public filings in this case. Given the lack of accessible information, no immediate trading action is warranted. Be cautious of potential information asymmetry if material details emerge later.

Key Facts

Case: Fraioli v. Regeneron Pharmaceuticals, Inc. et al, filed 2026-03-30 in the Southern District of Florida (Case No. 1:26-cv-20636)
No ruling text or docket entries available — only a login redirect for PACER system
Plaintiff is Fraioli; Regeneron is named as defendant
Nature of suit or claims cannot be determined from available data

Financial Impact

Unknown — no information on damages, injunctions, or settlement

Risk Factors

Potential for material undisclosed litigation risk if the case involves securities, product liability, or regulatory claims
Low visibility increases uncertainty, which could lead to volatility if details are later disclosed

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

75% bullish (36 analysts)

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

Document	Accession Number
COURT-RULING Data (Synthetic)	court-iczfz1rr-REGN

14 reports for REGN

T+1T+5T+20T+60

25% Hit rate 2 of 8 directional calls best @ T+1▲ +1.29%Apr 13, 2026

Filters

Reports for REGN — sortable, filterable
	Type				Now
May 31, 2026 9d ago	ANALYST-UPGRADE BULLISH ★ 3/10	$810.25 $752.29	▼ −7.15%	▼ −7.28%	$611.34 (−24.55%)
May 21, 2026 19d ago	Press Release BULLISH ★ 6/10	$638.53 $600.65	▼ −5.93%	▼ −7.59%	$611.34 (−4.26%)
May 18, 2026 22d ago	ANALYST-DOWNGRADE BEARISH ★ 2/10	$629.34 $632.17	▼ −0.45%	▲ +1.17%	$611.34 (+2.86%)
May 18, 2026 22d ago	Press Release NEUTRAL ★ 4/10	$629.34 $632.17	▲ +0.45%	▼ −1.17%	$611.34 (−2.86%)
May 16, 2026 25d ago	Press Release BEARISH ★ 7/10	$629.34 $632.17	▼ −0.45%	▲ +1.17%	$611.34 (+2.86%)
May 15, 2026 25d ago	Press Release NEUTRAL ★ 2/10	$696.20 $638.53	▼ −8.28%	▼ −9.25%	$611.34 (−12.19%)
May 1, 2026 5w ago	ANALYST-UPGRADE BULLISH ★ 4/10	$810.25 $752.29	▼ −7.15%	▼ −7.28%	$611.34 (−24.55%)
Apr 24, 2026 6w ago	DEFA14A NEUTRAL ★ 3/10	$744.35 $709.19	▼ −4.72%	▼ −5.12%	$611.34 (−17.87%)
Apr 21, 2026 7w ago	Press Release BULLISH ★ 8/10	$747.15 $729.36	▼ −2.38%	▼ −3.46%	$611.34 (−18.18%)
Apr 13, 2026 8w ago	Press Release BULLISH ★ 7/10	$745.61 $749.26	▲ +0.49%	▼ −2.81%	$611.34 (−18.01%)

US Market Status

Market Closed — Opens in 6h 58m

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access